Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapy.

× No keyword cloud information.

3 in total

1. Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations.

Authors: Sylvie D Freeman; Robert K Hills; Paul Virgo; Naeem Khan; Steve Couzens; Richard Dillon; Amanda Gilkes; Laura Upton; Ove Juul Nielsen; James D Cavenagh; Gail Jones; Asim Khwaja; Paul Cahalin; Ian Thomas; David Grimwade; Alan K Burnett; Nigel H Russell
Journal: J Clin Oncol Date: 2018-03-30 Impact factor: 44.544

2. Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses.

Authors: Alan K Burnett; Nigel H Russell; Robert K Hills; Stephen Knapper; Sylvie Freeman; Brian Huntly; Richard E Clark; Ian F Thomas; Lars Kjeldsen; Mary Frances McMullin; Mark Drummond; Jonathan Kell; Ruth Spearing
Journal: J Clin Oncol Date: 2020-12-23 Impact factor: 44.544

3. High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.

Authors: Miriam Marquis; Cyrielle Beaubois; Vincent-Philippe Lavallée; Michal Abrahamowicz; Coraline Danieli; Sébastien Lemieux; Imran Ahmad; Andrew Wei; Stephen B Ting; Shaun Fleming; Anthony Schwarer; David Grimwade; William Grey; Robert K Hills; Paresh Vyas; Nigel Russell; Guy Sauvageau; Josée Hébert
Journal: Blood Cancer J Date: 2018-07-19 Impact factor: 11.037

3 in total